INTRODUCTION
The life-long production of blood cells depends on the regenerative capacity of a small population of hematopoietic stem cells (HSCs) that reside normally in the bone marrow, in the adult. This property forms the basis of HSC assays in which grafted donor cells are tested for their capacities for long-term reconstitution in all blood lineages of a transplanted host. The long-term persistence of clones initiated by HSCs depends critically on their ability to sustain self-renewal over time and over multiple HSC divisions, thus their capacity for life-long blood cell production. HSCs with reconstituting potential that do not sustain self-renewal activity generate clones that eventually lose stem cell activity and are detectable as transient reconstitutions in transplantation assays 1 
.
The mechanisms that sustain self-renewal remain to be further elucidated since only a few genes have been implicated in this process (reviewed in 2 ).
In the adult, HSCs mostly reside in G0 3 and are triggered into cycling by chemotoxic injuries 4 , by exposure to cytokines in vitro 5 , or by transplantation in vivo 6 . The state of quiescence in HSCs is reversible 3 and differs from quiescence associated with senescence, differentiation or growth factor deprivation (reviewed in 2, 7 ). This suggests the existence of mechanisms that actively maintain HSCs in G0. Such regulation is critical for long-term stem cell function 2 as exemplified by several gene deletion models.
HSC from mice that are deficient for Cdkn1a or Id1 exhibit impaired long term activity, associated with increased cycling 8, 9 . In addition, HSC quiescence is maintained by the opposing activities of GFI1 10,11 and MEF 12 , although the transcriptional circuitry that actively maintains HSC quiescence remains to be documented 13 .
For personal use only. on September 14, 2017. by guest www.bloodjournal.org From Cell cycle and quiescence are actively controlled at critical transition points in the hematopoietic hierarchy. Unlike HSCs, a significant proportion of hematopoietic progenitors are found in S phase. For example, erythroid progenitors are highly proliferative 14, 15 , while transition to terminal erythroid differentiation is coupled with growth arrest. We recently showed that the SCL transcription factor controls the transition between a proliferative state and commitment to differentiation and growth arrest in erythroid progenitors by upregulating Gfi1b and Cdkn1a expression 16 25 . In the present study, we address the role of SCL in HSC quiescence control and their long-term integrity.
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METHODS

Mice
Scl
+/-mice 26 were a generous gift from Dr Glenn C. Begley (Amgen Inc., Thousand
Oaks, CA, USA). These mice were maintained on a C57BL/6 background for more than For personal use only. on September 14, 2017. by guest www.bloodjournal.org From FCS, followed by Pyronin Y labelling (1 µg/mL, Sigma-Aldrich, Oakville, ON) for 30 min. Cells were then washed and labelled for cell surface markers (Kit, Sca1, CD150, CD48 and Lin). Where indicated, lineage-depleted cells were stimulated in culture for 24h with Steel Factor (100 ng/ml), IL-11 (100 ng/ml), IL-6 (10 ng/ml). Cell cycle analyses were performed on the LSRII at low flow rate.
For BrdU labelling and staining, mice received an initial intraperitoneal injection of 3 mg of BrdU, followed by 3 days of BrdU in drinking water (1 mg/ml). BrdU incorporation in LT-HSCs was detected by flow cytometry with the FITC-BrdU flow kit (BD Biosciences, Mississauga, ON).
Fluorescein-di-β-D-galactopyranoside staining
β-galactosidase activity was analysed as described using the Scl-lacZ-knock in mouse model 26 to track Scl gene expression in HSCs and progenitors 30 .
Gene expression analysis and western blotting
For RT-PCR analysis, total RNA was extracted from 10 000 FACS-purified cells (FACS ARIA) for reverse transcription, as described 55 . PCR primers and antibodies used for western blotting are described in Supplemental Material.
Transplantation assays
Limiting dilution analysis was performed essentially as described 31 
The input mixture was assessed by flow cytometry prior to transplantation to obtain the exact input T/C ratio. 
Statistical analyses
Where indicated, groups were compared using the Student t test. To address the possibility that Scl expression correlates with quiescence ( Figure 1A-D) , we subdivided the LT-HSC population into G0 and non-G0 (G1/S/G2/M) fractions and found that Scl expression is higher in the G0 fraction and lower in the other fractions ( Figure 1E ). Interestingly, this expression pattern was also observed with Cdkn1a, an SCL target gene in erythroid progenitors 16 , encoding a negative regulator of the cell cycle. Together, our observations indicate that Scl expression is highest in resting LTHSCs, whilst its expression is lowered with cell cycle entry.
Reducing SCL level impairs HSC functions
To assess the role of Scl in HSC activity, we took advantage of the Scl +/-mouse ( Figure   2A ) in which we observed a two-fold decrease of both p42 and p22 SCL protein isoforms in lineage depleted bone marrow cells when compared to Scl +/+ cells, whereas E47 and PTP1D levels remained constant ( Figure 2B Finally, we ruled out a possible non cell autonomous contribution to the phenotype of Scl +/-HSCs. Indeed, the capacity of HSCs to reconstitute hematopoiesis was similar when wild type bone marrow cells were transplanted into Scl +/+ or Scl +/-irradiated mice (Supplemental Figure S2B ).
The above observations suggest that Scl levels regulate long term HSC competence.
Alternatively, it is possible that these stem cell defects arose during development. To address this question, we took an independent approach to decrease Scl levels in adult 
SCL restrains the cell cycle in LT-HSCs
The long term competence of stem cells has been linked to quiescence control 2, 7 .
Furthermore, our observations indicate a correlation between Scl levels and quiescence ( Figure 1 ). We therefore addressed the question whether the cell cycle status of LT-HSCs was affected by Scl RNA interference or reduced Scl gene dosage.
Analysis of cell cycle parameters in the population enriched in LT-HSC using Hoechst and Pyronin staining indicated that Scl shRNA infection resulted in a three-fold increase in the G1 fraction ( Figure 4D ). The same effects were observed with three different
shRNAs when compared to a non targeting control, suggesting that these were specifically due to decreased SCL protein levels. Furthermore, populations that are Furthermore, we did not observe differences in cytokine-induced cell cycle progression when Scl +/+ and Scl +/-LT-HSCs from 3-week old mice were compared ( Figure 6D ). We therefore conclude that decreasing Scl gene dosage facilitates the G0-G1 transition in adult LT-HSCs in vivo and in vitro.
SCL controls Cdkn1a and Id1 gene expression in HSCs
We next assessed whether SCL levels affect the expression levels of known cell cycle Figure S4A) whereas Mef proximal promoter contains non-consensus E boxes. We designed PCR primers in the vicinity of these E boxes ( Figure 7C ) for chromatin immunoprecipitation of purified Lin − cells. Cdkn1a and Id1 promoter sequences were specifically immunoprecipitated by the SCL antibody compared to control immunoglobulins whereas Mef promoter sequences and β-actin control sequences were not ( Figure 7D Figure S4B) . We therefore conclude that the Cdkn1a and Id1 genes are direct SCL targets and their expression is sensitive to Scl gene dosage.
For
DISCUSSION
In the present study, we show that SCL controls HSC long term competence and restrains the G0-G1 transition in these cells. Furthermore, SCL directly regulates the expression of two genes involved in HSC quiescence, Id1 and the cell cycle regulator Cdkn1a. For
SCL regulates the G0-G1 progression of LT-HSC
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SCL controls HSC function under proliferative stress
In the adult, HSCs must achieve a balance between quiescence and rapid cell cycle entry upon conditions of high proliferative demand, to fulfil immediate requirements for mature hematopoietic cells without compromising the maintenance of the stem cell pool. 
Quiescence and self-renewal
An essential hallmark of LT-HSCs is their capacity for sustained self-renewal. Indeed, ST-HSCs are also capable of undergoing self-renewal divisions, but are unable to maintain hematopoiesis in the long term. Sustainability is therefore a true stem cell characteristic. Self-renewal divisions can lead to expansion, as observed during ontogeny when the stem pool increases in size, or to maintenance in the adult, preserving HSC numbers and functions throughout the entire life span of the organism. Very few transcriptional regulators are known to be involved in this long term maintenance and our observations indicate an important role for Scl gene dosage in this process. 
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